Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major

BACKGROUND AND AIMS: β-thalassemia major patients are susceptible to Hepatitis C Virus (HCV) infection owing to life-long dependency for blood-transfusion. Moreover, this patient population is at risk of progression of liver fibrosis or development of cirrhosis as a consequence of both iron overload...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Exp Hepatol
Autors principals: Mehta, Rajiv, Kabrawala, Mayank, Nandwani, Subhash, Desai, Pankaj, Bhayani, Vishwa, Patel, Sanjay, Parekh, Viral
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938522/
https://ncbi.nlm.nih.gov/pubmed/29743790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.06.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars